• PROFESSOR
  • Professor
PROFESSOR

Professor

Hong-Hee Kim

Professor
Seoul National University School of Dentistry

82-2-740-8686, 8738 hhbkim@snu.ac.kr

Education

  • Ph.D., University of Iowa, Medical School Department of Pharmacolology, 1990. 6. - 1995. 8.
  • BS, Seoul National University College of Pharmacy, Department of Pharmacolology, 1982. 3. - 1986. 2.

PROFESSIONAL EXPERIENCE

  • Seoul National University School of Dentistry, 2010. 4. – present
    -Professor
  • Bone Metabolism Research Center, 2008. 9. – 2015. 2.
    -Director
  • Seoul National University School of Dentistry, 2005. 4. - 2010. 3
    -Associate Prof.
  • Seoul National University School of Dentistry, 2003. 3. - 2005. 3.
    -Assistant Prof.
  • Chosun University School of Dentistry, 2000. 4. - 2003. 2.
    -Assistant Prof.
  • Chosun University School of Dentistry, 1997. 11. - 2000. 3.
    -Instructor
  • Harvard Medical School/DFCI, 1995. 8. - 1997. 10.
    -Research Associate

Society Activities

  • The Korean Academy of Science and Technology, 2015. 1.1 - present
    Member
  • BONE, 2013. 7.1-2018.6.30
    Editor
  • Korean Society for Bone and Mineral Research, 2013.6.1 - 2015.5.31
    Vice President
  • Korean Society for Molecular and Cellular Biology, 2008.1.1 - 2009.12.31
    Mol Cells Associate Editor
  • The Pharmaceutical Society of Korea, 2005.1.1 - 2005.12.31
    APR Associate Editor

Representative Publications

  • Ryu J, Kim HJ, Chang EJ, Huang H, Banno Y, and Kim HH (2006). Sphingosine 1-phosphate as a regulator for osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J 25:5840-5851.
  • Lee Y, Hyung SW, Jung HJ, Kim HJ, Staerk J, Constantinescu SN, Chang EJ, Lee ZH, Lee SW, and Kim HH (2008). The ubiquitin-mediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon-beta-induced inhibitory signaling. Blood 111:885-893.
  • Chang EJ, Jeongim Ha J, Oerlemans F, Lee YJ, Lee SW, Ryu J, Kim HJ, Lee Y, Kim HM, Choi JY, Kim JY, Shin CS, Pak YK, Tanaka S, Wieringa B, Lee ZH, and Kim HH (2008). Brain-type creatine kinase has a crucial role in osteoclast-mediated bone resorption. Nature Medicine 14:966-972.
  • Ha J, Choi HS, Lee Y, Kwon HJ, Song YW, Kim HH* (2010). CXC chemokine ligand 2 induced by receptor activator of NF-kappaB ligand enhances osteoclastogenesis. J Immunol. 184:4717-4724.
  • Lee Y, Kim HJ, Park CK, Kim WS, Lee ZH, Kim HH* (2012). Novel extraneural role of neurite outgrowth inhibitor A: modulation of osteoclastogenesis via positive feedback regulation of nuclear factor of activated T cell cytoplasmic 1. J Bone Miner Res. 27:1043-1054.
  • Kim HJ, Prasad V, Hyung SW, Lee ZH, Lee SW, Bhargava A, Pearce D, Lee Y, Kim HH* (2012). Plasma membrane calcium ATPase regulates bone mass by fine-tuning osteoclast differentiation and survival. J Cell Biol. 199:1145-1158.
  • Park CK, Lee Y, Kim KH, Lee ZH, Joo M*, Kim HH* (2014). Nrf2 is a novel regulator of bone acquisition. Bone 63:36-46.
  • Lee YD, Yoon SH, Park CK, Lee J, Lee ZH, Kim HH* (2015). Caveolin-1 Regulates Osteoclastogenesis and Bone Metabolism in a Sex-dependent Manner. J Biol Chem. 290:6522-30.
  • Kim H, Lee YD, Kim HJ, Lee ZH, Kim HH* (2017). SOD2 and Sirt3 Control Osteoclastogenesis by Regulating Mitochondrial ROS. J Bone Miner Res. 32:397-406.